Artificial Intelligence in Drug Discovery Market Size & Growth

Source Domain: www.openpr.com

Here is an unordered list summarizing the key points of the provided article on the “Artificial Intelligence in Drug Discovery Market”:

* The market is expected to grow significantly, reaching approximately USD 6.89 billion by 2029, up from USD 1.86 billion in 2024, with a compound annual growth rate (CAGR) of 29.9% from 2024 to 2029.
* Notable market players include major technology companies such as NVIDIA Corporation, Microsoft Corporation, and Google, along with specialized firms like Exscientia, Schrodinger, and Atomwise, who are leveraging AI for drug discovery.
* The market segmentation includes various processes, tools, therapies, and end-users. Machine learning stands as the dominant and fastest-growing AI tool in this space.
* North America dominates the market primarily due to the U.S. FDA’s favorable approval stance for AI-discovered drug candidates and regional advances in IT infrastructure in the pharmaceutical and biotech sectors.
* Essential market growth drivers include the demand to cut down on drug discovery’s time and cost, the expanding oncology drug pipeline, and initiatives aiming at rare disease research.
* Despite significant growth potential, the market may face challenges such as limited availability of datasets for comprehensive AI training.